Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3D-PREDICT REGISTRY: 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells From Tumors

NCT03561207 is registered in ClinicalTrials.gov with KIYATEC as lead sponsor.

NCT NCT03561207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3D-PREDICT REGISTRY: 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells From Tumors
Lead sponsor
KIYATEC
Phase
Observational
Overall status
Unknown status
Start date
June 11, 2018
Completion date
December 31, 2024
Enrollment
570 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, anaplastic astrocytoma, glioblastoma multiforme, ovarian cancer